30 January 2025
MSD supports the Trinity Challenge’s advocacy and engagement on antibiotic resistance
The Trinity Challenge, a charity supporting the creation of data-driven solutions to help protect against global health threats, has welcomed a generous contribution from MSD to support advocacy activities from the winners of Trinity Challenge on Antimicrobial Resistance, an innovation prize which has been awarded to four solutions with plans to tackle antibiotic resistance in low- and middle-income countries.
This support will allow Trinity Challenge winners to deliver engagement and advocacy work on antibiotic resistance. The winners are delivering solutions aiming to both fill knowledge gaps and raise awareness, thereby paving the way for action to mitigate the antibiotic emergency. Data-driven solutions such as Farm2Vet and AMRSense include policy-makers among their audiences, aiming to make the case for the value of data integration and predictive analytics for decision-making on antibiotic resistance policy.
Professor Marc Mendelson, Director, the Trinity Challenge, said: “We are very pleased and grateful that the Trinity Challenge has received this funding. We welcome MSD to our group of industry-leading supporters who are committed to taking action with us. Their support will help optimise our ongoing efforts throughout our network of winning projects to drive progress in the response to antibiotic resistance.”
Jenelle Krishnamoorthy, Vice President, Head of Global Public Policy and International Affairs at MSD, said: “We are proud to support the Trinity Challenge on Antimicrobial Resistance winners as we all work together to address this global public health threat. Swift and collaborative action is urgently needed to address antimicrobial resistance, especially in low- and middle-income countries where the greatest impact occurs.”
About Antimicrobial Resistance
Antimicrobials are drugs used to combat bacteria (antibiotics), fungi (antifungals), viruses (antivirals) and parasites (antiparasitics).
Antimicrobial resistance happens when the microbes that cause infections evolve, stopping the medicines designed to kill them from working. This leads to treatments becoming ineffective and allowing infections to become increasingly difficult, or in some cases, impossible to treat. In the case of bacteria, this process is called antibiotic resistance, and this is the focus of the Trinity Challenge on Antimicrobial Resistance.
The speed at which antibiotic resistance is growing is a direct response to misuse and overuse of antibiotics across our healthcare systems and the food industry. The situation with respect to antibiotic resistance in bacteria has developed to the point that it now threatens our health, food, environment and global security. Without action, by 2050, it is estimated that 39 million deaths will be directly caused by AMR.
About the Trinity Challenge
The Trinity Challenge (TTC) is a charity supporting the creation of data-driven solutions to help protect against global health threats.
The Trinity Challenge on Antimicrobial resistance received applications from 285 teams in 57 countries and distributed a prize fund of £2.7 million across four winning initiatives.
We believe data and analytics hold the key to building effective, affordable, and scalable solutions to current and future pandemics and health emergencies, and we are committed to working with governments, individuals and organisations across the world, to help improve our resilience against current and future threats to global health.
